查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425764

2024 年狂犬病诊断全球市场报告

Rabies Diagnostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，狂犬病诊断的市场规模一直在强劲成长。 2028 年将达到 21.9 亿美元，复合年增长率为 6.5%。过去，成长归因于多种因素，包括全球化和旅行模式、「同一个健康」方法的采用、监管标准的製定、动物测试的进步以及环境因素的影响。这些综合因素对观察到的成长做出了重大贡献。

2023 年狂犬病诊断市场最大的地区是北美。狂犬病诊断市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球狂犬病诊断市场的驱动与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球狂犬病诊断市场规模表现与成长
  • 2023-2028、2033年全球狂犬病诊断市场规模及成长预测

第六章市场区隔

  • 全球狂犬病诊断市场，依诊断方法细分、绩效与预测，2018-2023、2023-2028、2033
  • 萤光抗体测试
  • 免疫组织化学
  • 扩增方法
  • 组织学检查
  • 血清学检测
  • 全球狂犬病诊断市场，按技术、性能和预测细分，2018-2023、2023-2028、2033
  • ELISA/免疫组织化学
  • 层析法技术
  • PCR
  • 其他的
  • 全球狂犬病诊断市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断中心
  • 癌症安宁疗护诊所
  • 其他的

第 7 章 区域与国家分析

  • 全球狂犬病诊断市场，按地区、绩效及预测，2018-2023年、2023-2028年、2033年
  • 全球狂犬病诊断市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 狂犬病诊断市场竞争形势
  • 狂犬病诊断市场公司概况
    • Bio-Rad Laboratories Inc.
    • The Merck Group
    • Aviva Systems Biology Corporation
    • Creative Diagnostics
    • Demeditec Diagnostics GmbH

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与潜力分析

第35章附录

简介目录
Product Code: r12995

Rabies Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
  • 2) By Technology: ELISA/Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
  • 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
  • Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. During the historic period, growth can be attributed to several factors including the patterns of globalization and travel, adoption of the One Health approach, development of regulatory standards, advancements in animal testing, and the influences stemming from environmental factors. These combined elements contributed significantly to the observed growth.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. In the forecast period, growth is expected due to rising rabies incidence rates, the environmental impact, cost-efficiency measures, ongoing research and development efforts, and the increasing need for surveillance. Significant trends anticipated during this period encompass government initiatives and vaccination programs, the influence of globalization and travel, the adoption of the One Health approach, heightened public health concerns, and the emergence of remote and point-of-care diagnostics. These trends are poised to shape the landscape of rabies diagnostics and treatment.

The growth trajectory of the rabies diagnostics market is expected to surge due to the increasing prevalence of rabies cases globally. Rabies, a preventable viral disease commonly transmitted through animal bites, affects the central nervous system, often leading to fatal brain damage. Diagnosis involves various tests to detect the virus in both humans and animals. The rising instances of infectious animal-transmitted diseases have significantly heightened the demand for rabies diagnostics. According to a May 2021 report by the World Health Organization, an estimated 59,000 people worldwide succumb to rabies annually, with over 29 million individuals receiving post-bite vaccinations. The economic toll of rabies amounts to approximately $8.6 billion per year. Hence, the growing prevalence of rabies is set to be a major driver for the rabies diagnostics market.

The ongoing trend of urbanization is anticipated to fuel the growth of the rabies diagnostics market. Urbanization, driven by economic growth and industrialization, transforms rural areas into urban hubs. In this transition, rabies diagnostics play a pivotal role in swiftly detecting and managing rabies outbreaks within densely populated urban settings, safeguarding public health. As per an April 2023 report by the World Bank Group, over half of the global population currently resides in urban areas, a figure projected to climb to 6 billion by 2045, marking a 1.5-fold increase. Consequently, the surging urbanization serves as a catalyst propelling the rabies diagnostics market forward.

Product innovation stands as a prominent trend shaping the rabies diagnostics market. Pharmaceutical manufacturers globally are focusing on developing sophisticated testing techniques within analytical chemistry to deliver precise and cost-effective analytical solutions. These testing products seamlessly integrate into routine sample testing processes. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based technology developer, unveiled the CFX Duet Real-Time PCR system. This clinical diagnostic device aids researchers in creating singleplex and duplex quantitative PCR (qPCR) tests, boasting enhanced thermal performance, a patented optical shuttle system, and thermal gradient functionality for optimization.

Major players in the rabies diagnostics market are strategically collaborating to gain a competitive advantage through rapid test kit development. These collaborations aim to introduce swift test kits into the market, sustaining their competitive edge. An example is the partnership between Oita University and ADTEC, a Japan-based pharmaceutical company, launched by the Japan International Cooperation Agency (JICA) and the Department of Agriculture - Bureau of Animal Industry (DA-BAI) in October 2021. The Immunochromatographic Test Kit (ICT Kit) developed under the ''Japan and Philippines One Health Rabies'' (JAPOHR) Project significantly reduces rabies diagnosis time from 2-3 hours to 20-30 minutes. These kits aim to bolster early detection of rabies in high-risk areas and support the rabies prevention program in the Philippines over the next two years through provision, evaluation, and necessary training on ICT kits.

In December 2021, Co-Diagnostics, Inc., a diagnostics test company based in the United States, completed the acquisition of Idaho Molecular Inc. and Advanced Conceptions Inc. This strategic acquisition, executed for an undisclosed sum, significantly bolstered Co-Diagnostics' market position, marking a pivotal move in their journey towards the next phase of growth. The acquisition is geared towards expanding the global availability of advanced healthcare solutions. Idaho Molecular Inc. and Advanced Conceptions Inc., both US-based companies specializing in diagnostic and therapeutic devices, operate within the rabies diagnostics market, augmenting Co-Diagnostics' presence in this sector.

Major companies operating in the rabies diagnostics market report are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.

North America was the largest region in the rabies diagnostics market in 2023. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Rabies Diagnostics Market Characteristics

3. Rabies Diagnostics Market Trends And Strategies

4. Rabies Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Rabies Diagnostics Market Size and Growth

  • 5.1. Global Rabies Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Rabies Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Rabies Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Rabies Diagnostics Market Segmentation

  • 6.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fluorescent Antibody Test
  • Immunohistochemical Test
  • Amplification Methods
  • Histologic Examination
  • Serology Tests
  • 6.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • ELISA/Immunohistochemistry
  • Chromatography Techniques
  • PCR
  • Other Technologies
  • 6.3. Global Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostic Centres
  • Cancer Palliative Care Clinics
  • Other End-Users

7. Rabies Diagnostics Market Regional And Country Analysis

  • 7.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Rabies Diagnostics Market

  • 8.1. Asia-Pacific Rabies Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Rabies Diagnostics Market

  • 9.1. China Rabies Diagnostics Market Overview
  • 9.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Rabies Diagnostics Market

  • 10.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Rabies Diagnostics Market

  • 11.1. Japan Rabies Diagnostics Market Overview
  • 11.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Rabies Diagnostics Market

  • 12.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Rabies Diagnostics Market

  • 13.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Rabies Diagnostics Market

  • 14.1. South Korea Rabies Diagnostics Market Overview
  • 14.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Rabies Diagnostics Market

  • 15.1. Western Europe Rabies Diagnostics Market Overview
  • 15.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Rabies Diagnostics Market

  • 16.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Rabies Diagnostics Market

  • 17.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Rabies Diagnostics Market

  • 18.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Rabies Diagnostics Market

  • 19.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Rabies Diagnostics Market

  • 20.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Rabies Diagnostics Market

  • 21.1. Eastern Europe Rabies Diagnostics Market Overview
  • 21.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Rabies Diagnostics Market

  • 22.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Rabies Diagnostics Market

  • 23.1. North America Rabies Diagnostics Market Overview
  • 23.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Rabies Diagnostics Market

  • 24.1. USA Rabies Diagnostics Market Overview
  • 24.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Rabies Diagnostics Market

  • 25.1. Canada Rabies Diagnostics Market Overview
  • 25.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Rabies Diagnostics Market

  • 26.1. South America Rabies Diagnostics Market Overview
  • 26.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Rabies Diagnostics Market

  • 27.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Rabies Diagnostics Market

  • 28.1. Middle East Rabies Diagnostics Market Overview
  • 28.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Rabies Diagnostics Market

  • 29.1. Africa Rabies Diagnostics Market Overview
  • 29.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Rabies Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Rabies Diagnostics Market Competitive Landscape
  • 30.2. Rabies Diagnostics Market Company Profiles
    • 30.2.1. Bio-Rad Laboratories Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. The Merck Group
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Aviva Systems Biology Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Creative Diagnostics
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Demeditec Diagnostics GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Rabies Diagnostics Market Competitive Benchmarking

32. Global Rabies Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Rabies Diagnostics Market

34. Rabies Diagnostics Market Future Outlook and Potential Analysis

  • 34.1 Rabies Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Rabies Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Rabies Diagnostics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer